These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28590055)

  • 1. Enhanced dissolution and bioavailability of Nateglinide by microenvironmental pH-regulated ternary solid dispersion: in-vitro and in-vivo evaluation.
    Wairkar S; Gaud R; Jadhav N
    J Pharm Pharmacol; 2017 Sep; 69(9):1099-1109. PubMed ID: 28590055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. II. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: co-milling.
    Maggi L; Bruni G; Maietta M; Canobbio A; Cardini A; Conte U
    Int J Pharm; 2013 Sep; 454(1):568-72. PubMed ID: 23872227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Amorphous Combination of Nateglinide-Metformin Hydrochloride for Dissolution Enhancement.
    Wairkar S; Gaud R
    AAPS PharmSciTech; 2016 Jun; 17(3):673-81. PubMed ID: 26314243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of semicrystalline polymers on self-emulsifying solid dispersions of nateglinide: in vitro and in vivo evaluation.
    Swain RP; Subudhi BB
    Drug Dev Ind Pharm; 2018 Jan; 44(1):56-65. PubMed ID: 28845687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: nanoparticles and co-mixing.
    Maggi L; Bruni G; Maietta M; Canobbio A; Cardini A; Conte U
    Int J Pharm; 2013 Sep; 454(1):562-7. PubMed ID: 23867985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility studies of nateglinide with excipients in immediate release tablets.
    Pani NR; Nath LK; Acharya S
    Acta Pharm; 2011 Jun; 61(2):237-47. PubMed ID: 21684850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
    Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
    Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Mohamed MS; Abdelhafez WA; Zayed G; Samy AM
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1973-1981. PubMed ID: 31692385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, optimisation, and in vitro-in vivo evaluation of febuxostat ternary solid dispersion.
    Tang J; Bao J; Shi X; Sheng X; Su W
    J Microencapsul; 2018 Aug; 35(5):454-466. PubMed ID: 30229692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of nateglinide controlled release tablet containing erosion matrix tablet and multiple administration study in normal beagle dogs.
    Makino C; Sakai H; Okano A; Yabuki A
    Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):907-13. PubMed ID: 19721250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000.
    Asyarie S; Rachmawati H
    PDA J Pharm Sci Technol; 2007; 61(5):400-10. PubMed ID: 18047178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N; Tadikonda R
    Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Characterization of Microstructured, Spray-Dried Co-Amorphous Mixture of Antidiabetic Agents Stabilized by Silicate.
    Wairkar S; Gaud R
    AAPS PharmSciTech; 2019 Mar; 20(3):141. PubMed ID: 30868308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid microcrystalline dispersion films as a new strategy to improve the dissolution rate of poorly water soluble drugs: A case study using olanzapine.
    Modica de Mohac L; de Fátima Pina M; Raimi-Abraham BT
    Int J Pharm; 2016 Jul; 508(1-2):42-50. PubMed ID: 27154255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies.
    McFall H; Sarabu S; Shankar V; Bandari S; Murthy SN; Kolter K; Langley N; Kim DW; Repka MA
    Int J Pharm; 2019 Jan; 554():302-311. PubMed ID: 30395959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
    Yang M; He S; Fan Y; Wang Y; Ge Z; Shan L; Gong W; Huang X; Tong Y; Gao C
    Int J Pharm; 2014 Nov; 475(1-2):97-109. PubMed ID: 25171976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Solubility and Bioavailability of Dolutegravir by Solid Dispersion Method: In Vitro and In Vivo Evaluation-a Potential Approach for HIV Therapy.
    Chaudhary S; Nair AB; Shah J; Gorain B; Jacob S; Shah H; Patel V
    AAPS PharmSciTech; 2021 Apr; 22(3):127. PubMed ID: 33835317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.